NO174668C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater

Info

Publication number
NO174668C
NO174668C NO892499A NO892499A NO174668C NO 174668 C NO174668 C NO 174668C NO 892499 A NO892499 A NO 892499A NO 892499 A NO892499 A NO 892499A NO 174668 C NO174668 C NO 174668C
Authority
NO
Norway
Prior art keywords
tetranor
inter
therapeutically active
analogous process
phenylene pgi2
Prior art date
Application number
NO892499A
Other languages
English (en)
Norwegian (no)
Other versions
NO892499D0 (no
NO174668B (no
NO892499L (no
Inventor
Kiyotaka Ohno
Toshiya Takahashi
Atsushi Ohtake
Hisanori Wakita
Shintaro Nishio
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO892499D0 publication Critical patent/NO892499D0/no
Publication of NO892499L publication Critical patent/NO892499L/no
Publication of NO174668B publication Critical patent/NO174668B/no
Publication of NO174668C publication Critical patent/NO174668C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NO892499A 1987-10-16 1989-06-15 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater NO174668C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26202187 1987-10-16
PCT/JP1988/001048 WO1989003387A1 (en) 1987-10-16 1988-10-14 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND USE THEREOF

Publications (4)

Publication Number Publication Date
NO892499D0 NO892499D0 (no) 1989-06-15
NO892499L NO892499L (no) 1989-08-16
NO174668B NO174668B (no) 1994-03-07
NO174668C true NO174668C (no) 1994-06-15

Family

ID=17369918

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892499A NO174668C (no) 1987-10-16 1989-06-15 Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater

Country Status (8)

Country Link
US (1) US5401768A (de)
EP (1) EP0365678B1 (de)
KR (1) KR960016541B1 (de)
DE (1) DE3886936T2 (de)
DK (1) DK296289A (de)
FI (1) FI102066B1 (de)
NO (1) NO174668C (de)
WO (1) WO1989003387A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589615A (en) * 1988-10-14 1996-12-31 Plant Genetic Systems N.V. Process for the production of transgenic plants with increased nutritional value via the expression of modified 2S storage albumins
CA2012081C (en) * 1989-03-14 2000-08-29 Shigeki Itou 2,5,6,7-tetranor-4,8-inter-m-phenylene pgi 2 derivatives
CA2107669C (en) * 1992-02-07 2004-06-01 Makoto Okumura Preparation for treating wounds and hemorrhoides
DE69620573T2 (de) * 1995-11-14 2002-08-08 Toray Industries, Inc. Mittel zur verminderung des augeninnendrucks
JP4314742B2 (ja) * 1997-09-16 2009-08-19 東レ株式会社 C−cケモカイン産生抑制剤
WO1999013881A1 (fr) * 1997-09-17 1999-03-25 Toray Industries, Inc. Agent de maturation cervical
EP1044972A4 (de) * 1998-10-23 2003-03-12 Toray Industries 5,6,7-TRINOR-4,8-INTER-m-PHENYLEN PGI2 DERIVATE UND SIE ENTHALTENDE MEDIKAMENTE
KR20020016938A (ko) 1999-08-05 2002-03-06 야스이 쇼사꾸 함질소화합물을 유효성분으로 하는 신경장해개선제
CN106748951B (zh) 2012-07-19 2020-07-24 开曼化学股份有限公司 作为在治疗ep4介导的疾病和病状中使用的ep4受体选择性激动剂的二氟内酰胺化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5732277A (en) * 1980-08-05 1982-02-20 Toray Ind Inc 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative
JPS57144276A (en) * 1981-03-03 1982-09-06 Toray Ind Inc 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivative
US4880939A (en) * 1986-12-11 1989-11-14 Toray Industries 2,5,6,7-tetranor-18,18,19,19-tetradehydro-4,8-inter-m-phenylene PGI2 derivatives
IL81215A (en) * 1987-01-09 1990-11-29 Israel Defence Two axis rate gyroscope

Also Published As

Publication number Publication date
NO892499D0 (no) 1989-06-15
EP0365678A1 (de) 1990-05-02
DK296289D0 (da) 1989-06-15
US5401768A (en) 1995-03-28
KR890701576A (ko) 1989-12-21
KR960016541B1 (en) 1996-12-14
NO174668B (no) 1994-03-07
WO1989003387A1 (en) 1989-04-20
DK296289A (da) 1989-08-01
NO892499L (no) 1989-08-16
FI892949A (fi) 1989-06-15
FI102066B (fi) 1998-10-15
DE3886936T2 (de) 1994-04-28
FI892949A0 (fi) 1989-06-15
DE3886936D1 (de) 1994-02-17
EP0365678B1 (de) 1994-01-05
FI102066B1 (fi) 1998-10-15
EP0365678A4 (de) 1990-02-20

Similar Documents

Publication Publication Date Title
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
NO175371C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyrederivater
NO180749C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolsubstituerte derivater
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO180084C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
NO175429C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater
NO178967C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazin-derivater
NO176142C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminoalkoksyfenylderivater
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
FI873350A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
NO176477C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-alkoksymetylsubstituerte kromanderivater
FI884660A0 (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
NO176100C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive oksodihydropyridyl- og oksodihydropyridazinylkromanderivater
NO174892C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser
NO175781C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive tetracykliske forbindelser
NO174668C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7 tetranor-4,8-inter-m-fenylen PGI2 derivater
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
FI98459B (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi
NO173332C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive tetrahydrofuranderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2001